Gene: ABCC6 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6 		0.050 Biomarker disease BEFREE Recently, a low intensity combination of CdA and ARA-C alternating with decitabine has shown promising results in older patients with AML. 31752577 2020
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6 		0.050 Biomarker disease BEFREE The aim of this study was to evaluate the efficacy and feasibility of intensified consolidation therapy employing fludarabine and ARA-C in cycle 1 and intermediate-dose ARA-C (IDAC) in cycles 2 through 4, in elderly acute myeloid leukemia (AML) patients and to analyze the effects of pegfilgrastim on the duration of neutropenia, overall toxicity, and hospitalization-time during consolidation in these patients. 28699225 2017
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6 		0.050 Biomarker disease BEFREE Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C). 23660386 2013
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6 		0.050 GeneticVariation disease BEFREE LDL increments were not correlated with cholesterol increments in ARA-C-treated AML samples. 15161671 2004
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6 		0.050 AlteredExpression disease BEFREE MRP2 and MRP6 mRNA were expressed predominantly in AML samples with 1 MRP1 signal, whereas in normal bone marrow cells no MRP2 and MRP6 mRNA was observed. 10828037 2000